JENNIFER STEGMILLER: Open Payments
NPI 1366914764 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 51 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $56 · 2025 $929
Food & beverage: $929
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $268 |
| ABBVIE INC. | 17 | $212 |
| Axsome Therapeutics, Inc. | 13 | $183 |
| Teva Pharmaceuticals USA, Inc. | 7 | $142 |
| Neurocrine BioSciences, Inc. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, Auvelity, AUSTEDO XR, INGREZZA, FANAPT, TRINTELLIX, UZEDY.
Industry payments across OH — which companies pay providers there.
